Evidence map›Paper›PMID 38201939›Full record

Trial reportNutrients2023

Mediterranean Diet, Vitamin D, and Hypercaloric, Hyperproteic Oral Supplements for Treating Sarcopenia in Patients with Heart Failure-A Randomized Clinical Trial.

Aura D Herrera-Martínez, Concepción Muñoz Jiménez, José López Aguilera, Manuel Crespin Crespin, Gregorio Manzano García, María Ángeles Gálvez Moreno, Alfonso Calañas Continente, María José Molina Puerta

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07356440 (Effect of Consumption of Vegetable Protein-enriched Biscuits and Vitamin D Supplementation on the Progression of Sarcopenia in Elderly Subjects), which is not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07356440 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Effect of Consumption of Vegetable Protein-enriched Biscuits and Vitamin D Supplementation on the Progression of Sarcopenia in Elderly Subjects

TypeinterventionalSponsorUniversity of UdineRan2025 to 2026Enrolled74ConditionsSarcopenia in Elderly, Sarcopenia, Nutritional Intervention, Microbiome AnalysisArmsVitamin D3 supplement, Protein-enriched biscuits, Control biscuit, Placebo oil
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Aura D Herrera-MartínezMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
Concepción Muñoz JiménezMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
José López AguileraMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
Manuel Crespin CrespinCardiology Service, Reina Sofia University Hospital, 14004 Córdoba, Spain.
Gregorio Manzano GarcíaMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
María Ángeles Gálvez MorenoMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
Alfonso Calañas ContinenteMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
María José Molina PuertaMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Córdoba, Spain.
Hospital Universitario Reina Sofía · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ES

Funding

Instituto de Salud Carlos III JR19/00050, PI23/01554Spanish society Endocrinology SEEN; Young Endocrinologist's Grant 2020; Junior Grant for Research Projects 2022
6 · The paper itself

Abstract

backgroundMalnutrition and sarcopenia frequently affect patients with heart failure (HF), in which clinical outcomes and survival is decreased. Thus, appropriate nutritional screening and early nutrition support are highly recommended. Currently, nutritional support is not a standard of care in patients with HF, and the use of commercially available oral supplements (OSs) could provide an additional benefit to medical treatment in these patients.

aimTo compare the effect of the Mediterranean diet in combination with hypercaloric, hyperproteic OS in patients with HF. PATIENTS AND

methodsAn open label, controlled clinical study in which patients were randomly assigned to receive a Mediterranean diet (control group) vs. hypercaloric, hyperproteic OS (intervention group) for twenty-four weeks. Thirty-eight patients were included; epidemiological, clinical, anthropometric, ultrasound (muscle echography of the rectus femoris muscle of the quadriceps and abdominal adipose tissue), and biochemical evaluations were performed. All patients received additional supplementation with vitamin D.

resultsBaseline malnutrition according to the GLIM criteria was observed in 30% of patients, while 65.8% presented with sarcopenia. Body cell mass, lean mass, and body mass increased in the intervention group (absolute increase of 0.5,

conclusionNutritional support with hypercaloric, hyperproteic OS, Mediterranean diet, and vitamin D supplementation were associated with decreased NT-proBNP and improvements in LVEF, functionality, and quality of life in patients with HF, despite a significant decrease in hospital admissions.

Indexed as

Diet, MediterraneanHeart FailureMalnutritionSarcopeniaHumansNutritional StatusNutrition AssessmentQuality of LifeVitamin DVitaminsVitamin DVitaminsheart failureLVEFNT-proBNPoral supplementssarcopenia

Identifiers

PMID38201939
PMCPMC10781070
OpenAlexW4390339363

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.